June 10, 2021

First, I apologize profusely for the gap in reporting. All is well in the Tippens family and I continue to be NED. The painstaking task of auditing success stories is much slower than I prefer, but I am proud there is actual traction finally happening in the scientific and clinical communities.


Without boring you with the details, the following paper was recently issued by Stanford University and University of Washington. The significance? All clinicians, scientists AND patients come from the project we started at the Oklahoma Medical Research Foundation to begin auditing success stories. To the thousands (millions actually) that have followed this with interest, I'm here to say that the "cat has left the barn"......and I am extremely proud. Please read


https://www.scitechnol.com/peer-review/fenbendazole-enhancing-antitumor-effect-a-case-series-2Kms.php?article_id=14307&fbclid=IwAR0tYpTZb4fp2_AO8e_WGWM5mcqv-RNfI-5SID9OWDcRiwHyHmQBKsjeSKk


Also: My continued research never ends. I am hopeful to be able to upgrade the protocol very soon with changes that I believe might be "game changers."